Company Filing History:
Years Active: 2011-2014
Title: Luyong Jiang: Innovator in Tyrosine Kinase Inhibitors
Introduction
Luyong Jiang, a distinguished inventor based in San Marcos, California, has made significant contributions to the field of medicinal chemistry. He holds a total of three patents, showcasing his expertise and innovation in developing compounds that target critical biological pathways.
Latest Patents
One of Luyong Jiang's latest patents focuses on tyrosine kinase inhibitors. This patent discloses compounds of the formula (I), including stereoisomers, tautomers, salts, hydrates, or prodrugs that modulate tyrosine kinase activity. Additionally, he has developed heterocyclic compounds that are useful in treating neoplastic diseases, inflammatory disorders, and immunomodulatory disorders. This invention also emphasizes compounds capable of modulating tyrosine kinases, compositions that include these compounds, and methods for their application.
Career Highlights
Luyong Jiang is currently associated with Chembridge Corporation, where his innovative work on pharmaceutical compounds has been pivotal. His research primarily revolves around identifying and developing compounds that can effectively target tyrosine kinases, which play a crucial role in various disease pathways.
Collaborations
Throughout his career, Luyong Jiang has collaborated with notable individuals in the field, including his coworkers Vlad Edward Gregor and Yahua Liu, contributing to a dynamic and innovative research environment.
Conclusion
With a robust portfolio of patents and a commitment to addressing complex medical challenges, Luyong Jiang exemplifies the spirit of innovation in pharmaceuticals. His work not only advances scientific understanding but also holds the potential to significantly impact the treatment of various diseases.